The involvement of cellular proliferation status in the expression of the human proto-oncogene DEK

Haematologica

Volumn 91, Issue 2, 2006, Pages 268-269

  Ageberg, Malin ^a,b   Gullberg, Urban ^a   Lindmark, Anders ^a  

^a LUND UNIVERSITY   (Sweden)

^b LUND UNIVERSITY   (Sweden)

Author keywords

DEK; Leukemia; Proliferation

Indexed keywords

ONCOPROTEIN; PROTEIN DEK; UNCLASSIFIED DRUG;

ARTICLE; BONE MARROW CELL; CELL PROLIFERATION; CONTROLLED STUDY; GENE EXPRESSION; GENETIC ANALYSIS; HUMAN; HUMAN CELL; HUMAN EXPERIMENT; POLYMORPHONUCLEAR CELL; PROTEIN EXPRESSION; PROTO ONCOGENE; REAL TIME POLYMERASE CHAIN REACTION;

BLOOD CELLS; BONE MARROW CELLS; CELL PROLIFERATION; CHROMOSOMAL PROTEINS, NON-HISTONE; GENE EXPRESSION REGULATION; HUMANS; ONCOGENE PROTEINS; PROTO-ONCOGENE PROTEINS; RNA, MESSENGER;

EID: 33644525948     PISSN: 03906078     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (8)

1. von Lindern M, Fornerod M, van Baal S, Jaegle M, de Wit T, Buijs A, et al. The translocation (6;9), associated with a specific subtype of acute myeloid leukemia, results in the fusion of two genes, dek and can, and the expression of a chimeric, leukemia-specific dek-can mRNA. Mol Cell Biol 1992;12:1687-97.
2. von Lindern M, Breems D, van Baal S, Adriaansen H, Grosveld G. Characterization of the translocation breakpoint sequences of two DEK-CAN fusion genes present in t(6;9) acute myeloid leukemia and a SET-CAN fusion gene found in a case of acute undifferentiated leukemia. Genes Chromosomes Cancer 1992;5:227-34.
3. Casas S, Nagy B, Elonen E, Aventin A, Larramendy ML, Sierra J, et al. Aberrant expression of HOXA9, DEK, CBL and CSF1R in acute myeloid leukemia. Leuk Lymphoma 2003;44:1935-41.
4. Kondoh N, Wakatsuki T, Ryo A, Hada A, Aihara T, Horiuchi S, et al. Identification and characterization of genes associated with human hepatocellular carcinogenesis. Cancer Res 1999;59:4990-6.
5. Grottke C, Mantwill K, Dietel M, Schadendorf D, Lage H. Identification of differentially expressed genes in human melanoma cells with acquired resistance to various antineoplastic drugs. Int J Cancer 2000;88:535-46.
6. + human marrow cells in vitro. Br J Haematol 2004;127:451-63.
7. Sitwala KV, Adams K, Markovitz DM. YY1 and NF-Y binding sites regulate the transcriptional activity of the dek and dek-can promoter. Oncogene 2002;21:8862-70.
8. Lin YM, Furukawa Y, Tsunoda T, Yue CT, Yang KC, Nakamura Y. Molecular diagnosis of colorectal tumors by expression profiles of 50 genes expressed differentially in adenomas and carcinomas. Oncogene 2002;21:4120-8.